Dimensional Fund Advisors LP Reduces Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)

Dimensional Fund Advisors LP decreased its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 7.9% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 113,850 shares of the medical instruments supplier's stock after selling 9,723 shares during the quarter. Dimensional Fund Advisors LP owned 2.10% of Mesa Laboratories worth $15,013,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Franklin Resources Inc. grew its stake in shares of Mesa Laboratories by 27.8% during the 3rd quarter. Franklin Resources Inc. now owns 6,444 shares of the medical instruments supplier's stock valued at $828,000 after acquiring an additional 1,403 shares during the period. Barclays PLC increased its stake in Mesa Laboratories by 357.4% in the third quarter. Barclays PLC now owns 8,837 shares of the medical instruments supplier's stock worth $1,148,000 after purchasing an additional 6,905 shares during the period. JPMorgan Chase & Co. increased its stake in shares of Mesa Laboratories by 29.3% during the third quarter. JPMorgan Chase & Co. now owns 8,406 shares of the medical instruments supplier's stock valued at $1,092,000 after buying an additional 1,906 shares during the period. Pacer Advisors Inc. increased its stake in shares of Mesa Laboratories by 4.3% during the fourth quarter. Pacer Advisors Inc. now owns 1,755 shares of the medical instruments supplier's stock valued at $231,000 after buying an additional 73 shares during the period. Finally, Conestoga Capital Advisors LLC boosted its position in Mesa Laboratories by 8.3% during the fourth quarter. Conestoga Capital Advisors LLC now owns 573,037 shares of the medical instruments supplier's stock valued at $75,566,000 after purchasing an additional 43,927 shares in the last quarter. Hedge funds and other institutional investors own 90.60% of the company's stock.

Insider Buying and Selling

In other Mesa Laboratories news, CEO Gary M. Owens sold 21,000 shares of the business's stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $123.91, for a total value of $2,602,110.00. Following the completion of the transaction, the chief executive officer now directly owns 43,337 shares of the company's stock, valued at approximately $5,369,887.67. The trade was a 32.64% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 4.40% of the company's stock.

Mesa Laboratories Stock Down 3.6%

MLAB stock traded down $4.56 during trading on Wednesday, reaching $122.38. 17,462 shares of the company traded hands, compared to its average volume of 39,459. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.53 and a current ratio of 0.71. The company has a market capitalization of $665.01 million, a price-to-earnings ratio of -2.65 and a beta of 0.97. The business has a 50 day simple moving average of $118.81 and a 200 day simple moving average of $126.57. Mesa Laboratories, Inc. has a 12 month low of $83.68 and a 12 month high of $155.12.

Mesa Laboratories Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, June 16th. Investors of record on Friday, May 30th will be issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.52%. The ex-dividend date of this dividend is Friday, May 30th. Mesa Laboratories's dividend payout ratio (DPR) is -1.38%.

Mesa Laboratories Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.